Christopher Thompson is a distinguished scientist in preclinical safety, currently serving as a Distinguished Scientist at Sanofi since 2023. Previously, they held the position of Head of Nonclinical Safety at Decibel Therapeutics from 2022 to 2023 and directed preclinical safety at Novartis Institutes for BioMedical Research from 2015 to 2022. Their early career included a role as a Dedicated Project Expert at sanofi-aventis between 2004 and 2015 and a postdoctoral position at CIIT from 2002 to 2004. Christopher earned a Doctor of Philosophy (PhD) in Biology from Tufts University and a Bachelor of Science (BS) in Biology from Boston College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices